BMRN vs BRK.B · P/E 40, rev $1.76B vs rev $371.44B
Biomarin Pharmaceutical Inc (BMRN) versus BRK.B (BRK.B) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
BRK.B (BRK.B) common stock. It is led by Warren Buffett.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported BRK.B revenue for 2025-12-31 was $371.44B. Net income was $66.97B. Revenue was up 616.8% from 2015-12-31 to 2025-12-31. BRK.B currently screens at market cap $0.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. BRK.B currently screens at market cap $0.
Not investment advice. Open the BMRN and BRK.B stock pages for the full models.
Not investment advice.